Clinical Trial Update: Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating serum anti-Mullerian hormone in polycystic ovary syndrome has completed, with results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: Assiut University | Conditions: Polycystic Ovary Syndrome | Phase 2 | Status: COMPLETED